A retrospective real-world study of nimotuzumab combined with chemotherapy for first-line treatment of advanced pancreatic cancer: A single center propensity score matched analysis

被引：0
|
作者：
Wu, Y. [1 ]
Dong, X. [2 ]
Li, E. [1 ]
Fan, Y. [2 ]
Dong, D. [3 ]
Shi, Y. [3 ]
Wang, M. [4 ]
Yang, N. [4 ]
Ou, F. [4 ]
Wang, J. [4 ]
Yang, Y. [4 ]
机构：
[1] Xi An Jiao Tong Univ, Med Coll, Affiliated Hosp 1, Med Oncol Dept, Xian, Peoples R China
[2] Xi An Jiao Tong Univ, Affiliated Hosp 1, Med Oncol, Xian, Peoples R China
[3] Xi An Jiao Tong Univ, Med Oncol, Xian, Peoples R China
[4] Xi An Jiao Tong Univ, Med Oncol, Sch Med, Xian, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2625
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1678P
引用
收藏
页码：S920 / S920
页数：1
相关论文
共 50 条
  • [41] Real-World Outcomes of Gemcitabine, Cisplatin, and Nab-Paclitaxel Chemotherapy Regimen for Advanced Biliary Tract Cancer: A Propensity Score-Matched Analysis
    Jung, Kwangrok
    Park, Jaewoo
    Jung, Jae Hyup
    Lee, Jong-Chan
    Kim, Jaihwan
    Hwang, Jin-Hyeok
    GUT AND LIVER, 2022, 16 (05) : 798 - 805
  • [42] Real-world outcomes of first-line maintenance therapy for recurrent or metastatic cervical cancer: A multi-center retrospective study
    Peng, Chen
    Li, Xiaolin
    Tang, Wenjie
    Zhu, Wanqi
    Yan, Peile
    Chen, Jinlong
    Zhang, Xueliang
    Guo, Qiufen
    Wu, Qian
    Wang, Qian
    Liu, Naifu
    Ma, Anqun
    Lu, Yuanyuan
    Lv, Pengzhong
    Liu, Jing
    Xie, Peng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 129
  • [43] FIRST-LINE MAINTENANCE AMONG ADVANCED OVARIAN CANCER PATIENTS IN THE US ONCOLOGY NETWORK: A REAL-WORLD RETROSPECTIVE COHORT STUDY
    Chase, Dana
    Liu, Jinan
    Moore-Schiltz, Laura
    Perhanidis, Jennifer
    Bulsara, Purva
    Patton, Gregory
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A33 - A33
  • [44] FOLFIRINOX versus Gemcitabine/nabPaclitaxel as First-line palliative Therapy in advanced Pancreatic Cancer: a Propensity-Score Analysis
    Riedl, Jakob M.
    Posch, Florian
    Gantschnigg, Antonia
    Horvath, Lena
    Renneberg, Felix
    Schwarzenbacher, Esther
    Moik, Florian
    Barth, Dominik
    Stotz, Michael
    Schaberl-Moser, Renate
    Pichler, Martin
    Stoeger, Herbert
    Greil, Richard
    Djanani, Angela
    Schlick, Konstantin
    Gerger, Armin
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 : 78 - 79
  • [45] First-line pemetrexed-platinum doublet chemotherapy with or without bevacizumab in non-squamous non-small cell lung cancer: A real-world propensity score-matched study in China
    Qi, Fei
    Hu, Xingsheng
    Liu, Yutao
    Wang, Zhijie
    Duan, Jianchun
    Wang, Jie
    Dong, Mei
    CHINESE JOURNAL OF CANCER RESEARCH, 2019, 31 (05) : 749 - 758
  • [46] First-line pemetrexed-platinum doublet chemotherapy with or without bevacizumab in non-squamous non-small cell lung cancer: A real-world propensity score-matched study in China
    Fei Qi
    Xingsheng Hu
    Yutao Liu
    Zhijie Wang
    Jianchun Duan
    Jie Wang
    Mei Dong
    Chinese Journal of Cancer Research, 2019, 31 (05) : 749 - 758
  • [47] Real-World Evidence of Ribociclib Plus Aromatase Inhibitors as First-Line Treatment in Advanced Breast Cancer: The BrasiLEEira Study
    Suzuki, Daniele Assad
    Morelle, Alessandra Menezes
    de Brito, Mayana Lopes
    Paes, Flavia Rocha
    Mattar, Andre
    Leal, Jorge H. Santos
    Simon, Sergio D.
    Lima, Ellias Magalhaes Abreu
    Werutsky, Gustavo
    Piotto, Gustavo H. Munhoz
    Bines, Jose
    Damiani, Lucas Petri
    Macedo, Ariane
    Campos, Ligia
    Buehler, Anna Maria
    JCO GLOBAL ONCOLOGY, 2024, 10
  • [48] Real-world first-line treatment patterns and outcomes in recurrent/advanced endometrial cancer patients in Europe
    Zhang, Jingchuan
    Kelkar, Sneha S.
    Prabhu, Vimalanand S.
    Ogando, Yoscar M.
    Verma, Rishi P.
    Grall, Veronique
    Marth, Christian
    FUTURE ONCOLOGY, 2024,
  • [49] Real-world prescribing patterns for first-line and maintenance treatment of patients with advanced urothelial cancer (UC)
    Inderjeeth, Andrisha-Jade
    O'haire, Sophie
    Gibbs, Peter
    Wong, Lih-Ming
    Zhang, Alison
    Manohar, Paul
    James, Lynam
    Sengupta, Shomik
    Wong, Shirley
    Weickhardt, Andrew
    Tran, Ben
    Conduit, Ciara
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 : 95 - 95
  • [50] Induction chemotherapy with sequential nimotuzumab plus concurrent chemoradiotherapy in advanced nasopharyngeal carcinoma: A retrospective real-world study
    Jiang, Danxian
    Cao, Jinxin
    Guo, Linying
    Chen, Yonghua
    Yuan, Ge
    Huang, Jing
    MEDICINE, 2023, 102 (04) : E32732
12345